Martin D Berger
Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin.
Adamina M, Warlaumont M, Berger M, Däster S, Delaloye R, Digklia A, Gloor B, Fritsch R, Koeberle D, Koessler T, Lehmann K, Müller P, Peterli R, Ris F, Steffen T, Weisshaupt C, Hübner M. Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin. Cancers (Basel) 2022; 14
01.09.2022Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin.
01.09.2022Cancers (Basel) 2022; 14
Adamina Michel, Warlaumont Maxime, Berger Martin D, Däster Silvio, Delaloye Raphaël, Digklia Antonia, Gloor Beat, Fritsch Ralph, Koeberle Dieter, Koessler Thibaud, Lehmann Kuno, Müller Phaedra, Peterli Ralph, Ris Frédéric, Steffen Thomas, Weisshaupt Christian, Hübner Martin
Development of a Score for Prediction of Occult Malignancy in Stroke Patients (Occult-5 Score).
Beyeler M, Birner B, Branca M, Meinel T, Vynckier J, Buffle E, Scutelnic A, Heldner M, Bücke P, Seiffge D, Mordasini P, Dobrocky T, Piechowiak E, Kaesmacher J, Gralla J, Mattle H, Arnold M, Fischer U, Pabst T, Berger M, Jung S. Development of a Score for Prediction of Occult Malignancy in Stroke Patients (Occult-5 Score). J Stroke Cerebrovasc Dis 2022; 31:106609.
23.06.2022Development of a Score for Prediction of Occult Malignancy in Stroke Patients (Occult-5 Score).
23.06.2022J Stroke Cerebrovasc Dis 2022; 31:106609
Beyeler Morin, Birner Barbara, Branca Mattia, Meinel Thomas Raphael, Vynckier Jan, Buffle Eric, Scutelnic Adrian, Heldner Mirjam R, Bücke Philipp, Seiffge David Julian, Mordasini Pasquale, Dobrocky Tomas, Piechowiak Eike Immo, Kaesmacher Johannes, Gralla Jan, Mattle Heinrich Paul, Arnold Marcel, Fischer Urs, Pabst Thomas, Berger Martin D, Jung Simon
Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08)
von Moos R, Plasswilm L, Zwahlen D, Meier U, Yan P, Izzo P, Klingbiel D, Bärtschi D, Zaugg K, Saletti P, Rauch D, Koeberle D, Schacher S, Hayoz S, Winterhalder R, Roth A, Bodoky G, Samaras P, Berger M, Swiss Group for Clinical Cancer Research (SAKK). Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08). Eur J Cancer 2017; 89:82-89.
11.12.2017Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08)
11.12.2017Eur J Cancer 2017; 89:82-89
von Moos Roger, Plasswilm Ludwig, Zwahlen Daniel, Meier Urs R, Yan Pu, Izzo Paola, Klingbiel Dirk, Bärtschi Daniela, Zaugg Kathrin, Saletti Piercarlo, Rauch Daniel, Koeberle Dieter, Schacher Sabina, Hayoz Stefanie, Winterhalder Ralph C, Roth Arnaud, Bodoky György, Samaras Panagiotis, Berger Martin D, Swiss Group for Clinical Cancer Research (SAKK)